Our commitment to diversity

 

As science improves, it has become clear that the way people respond to medicines is different. Genetics, ethnicity and even cultural differences play a part. Minorities have a higher rate of certain diseases compared to Caucasians. Why is that? And what can be done about it? Our goal at Lilly is to answer those very important questions and understand the unique needs of the people who depend on our medicines. We know that finding answers to those questions may help you and the ones you love. And, it will carry out our mission: making medicines that help people live longer, healthier and more active lives.

Here are ways Lilly is getting involved in this effort:

  • Important information about how medicines work in different racial and ethnic groups is not always available. Lilly has taken a leading role in the industry in enrolling people of different racial and ethnic groups into U.S. clinical trials. Clinical trials are part of the important research process in testing new medicines and treatments.
  • Our focus on diversity also extends to our educational outreach. Lilly works alongside patient advocacy groups, professional societies, public and private health care administrators and others to close the gaps in health care and to address the unique needs of diverse communities.
Commitment to Diversity

Commitment to Diversity

Lilly’s pledge to diversity helps generate ideas, solutions and innovations.

Clinical Trials

Clinical Trials

Learn more about Lilly’s Clinical Diversity Strategy and clinical trials.